Monaco Asset Management SAM »

Cytokinetics shares owned by Monaco Asset Management SAM

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Monaco Asset Management SAM from 13F filings

Historical chart of Monaco Asset Management SAM investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Monaco Asset Management SAM consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Monaco Asset Management SAM

Quarter filed Position value Share count Share price at filing
2025-09-30 $6.6M 120k 54.96
2025-06-30 $1.4M 43k 33.04

More positions owned by Monaco Asset Management SAM

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Silver Tr Ishares Call Option (SLV)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Ishares Msci Brazil Etf Call Option (EWZ)
Microsoft Corporation Put Option (MSFT)
Costco Wholesale Corporation Put Option (COST)
Vaneck Etf Trust Semiconductr Etf Put Option (SMH)
NVIDIA Corporation Put Option (NVDA)
Eli Lilly & Co. Put Option (LLY)
Viatris (VTRS)
AutoZone Put Option (AZO)
Patterson-UTI Energy (PTEN)
Vale S A Sponsored Ads (VALE)
Select Sector Spdr Tr Sbi Healthcare Put Option (XLV)
Lululemon Athletica (LULU)

View all positions for Monaco Asset Management SAM

Top funds holding Cytokinetics

T. Rowe Price Investment Management
BlackRock
FMR
Vanguard Group
Wellington Management Company
Tudor Investment Corporation
State Street Corporation
Deep Track Capital
Geode Capital Management
Polar Capital Holdings
Rtw Investments
Susquehanna International
Integral Health Asset Management
Armistice Capital
UBS Group

View all funds holding Cytokinetics